NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models.
Gruijs M, Ganzevles SH, Stigter-van Walsum M, van der Mast R, van Ostaijen-Ten Dam MM, Tuk CW, Schilham MW, Leemans CR, Brakenhoff RH, van Egmond M, van de Ven R, Bakema JE.
Gruijs M, et al. Among authors: van der mast r, van de ven r, van ostaijen ten dam mm, van egmond m.
Int J Mol Sci. 2021 Oct 14;22(20):11057. doi: 10.3390/ijms222011057.
Int J Mol Sci. 2021.
PMID: 34681717
Free PMC article.